Table 1 shows the characteristics of all 20 studies.[27–46] These studies mainly assessed the association between the mRNA expression of SIX1, SIX2, SIX3, SIX4, SIX5, and SIX6 with clinical parameters of breast cancer. Here, SIX4 is linked to breast carcinoma.